Subscribe
Share
Share
Embed
In this episode of “Lab Medicine Rounds,” Justin Kreuter, M.D., sits down with Medhat Askar, M.D., Ph.D., MSHPE, FRCPath, Professor of Pathology, Texas A&M College of Medicine, and Director of Clinical Services, National Marrow Donor Program (NMDP)/BeTheMatch. Listen as they discuss a very important topic this holiday season: the gift of organ donation.
A Mayo Clinic podcast for laboratory professionals, physicians, and students, hosted by Justin Kreuter, M.D., assistant professor of laboratory medicine and pathology at Mayo Clinic, featuring educational topics and insightful takeaways to apply in your practice.
(bright pulsing electronic music)
- This is Lab Medicine Rounds,
a curated podcast
for physicians, laboratory
professionals, and students.
I'm your host, Justin Kreuter,
the Bow Tie Bandit of Blood,
a transfusion medicine
pathologist at Mayo Clinic.
Today, we're really fortunate,
we're rounding with Dr. Medhat Askar,
Director of Clinical Services
for the National Marrow Donor
Program, NMDP, Be the Match,
here in Minneapolis, Minnesota,
and Clinical Professor of
Pathology and Laboratory Medicine
at Texas A&M Health Science
Center College of Medicine
in Bryan, Texas.
Additionally, Dr. Askar is
the Director of Transplant
Immunology, COVID-19,
and Facility Director for the
Cell Processing Laboratory
at Baylor University Medical
Center in Dallas, Texas.
He is also a Clinical Consultant
for the Department of Laboratory Medicine
Memorial Sloan Kettering Cancer Center
in New York, New York,
and the Head of Clinical
Immunology Division,
Department of Laboratory
Medicine Pathology
for Harvard Medical
Corporation in Doha, Qatar.
In addition to all of these roles,
Dr. Askar holds leadership roles
for several committees and societies
involved with
histocompatibility, and so today,
we're really fortunate to have Dr. Askar
take us through this
really important topic,
which is fitting for the
holiday season, right,
transplantation, the ultimate
gift that we all can give.
So thanks for joining us today, Dr. Askar.
- Thank you very much, Justin,
for this very kind introduction.
- I know it was a little
bit longer, but I mean,
all the roles you have, I
wanted to do it justice,
plus for the audience to understand,
you're really bringing a lot
of expertise to the table.
- Thank you, I appreciate.
- [Justin] So.
- I'm glad to be here
- As you get started in this,
how did you get started in the
field of histocompatibility?
- It's very interesting.
I'm still to meet someone
who went to medical
school on day one saying,
"I wanna become
histocompatibility specialist,"
it's just something we
don't normally hear about
in medical school.
And I initially started
out like most people,
very traditional specialty,
I started residency in
orthopedic surgery back in Egypt,
and soon I realized that
I want something more.
I mean, I hope my surgical
colleagues do not get offended,
but something really more analytical,
where you are confident 100% is
that what you see is what you think it is,
even if you have to repeat it 100 times.
And the only branch in medicine
you can do this legitimately,
you cannot cut the patient
open different ways
and see how that the cut was,
did it work for the patient?
But you can legitimately repeat testing
until you are convinced that
you have very accurate result,
and that's really what
attracted me to lab medicine.
But within lab medicine,
I wanted to do something
very cutting edge and very innovative
and also have a very high impact.
And these factors
came together in transplant immunology,
because especially when I
started this in '95 in Egypt,
there was hardly any transplant
taking place in Egypt,
but I was fascinated by it.
Something very unique
about transplantation,
it has such profound
impact on patient's life.
Patient come in cardiogenic shock,
like they're almost dead,
and two years later,
they are playing tennis,
like which specialty you
would have to see this.
- That's fascinating.
So was that a mentor
that helped you find this
new role and pathway,
or was there a particular
patient that you took care of
that opened your eyes
to these other possibilities
in lab medicine?
- No, I actually, I took a step
back from what I was doing.
I realized that surgery is
probably not right for me,
and I needed to figure out something else,
and by research and talking to people,
but I also had influential
transplant immunology mentors
that I gravitated to.
- Wow, this is fascinating.
I wanna make sure that the listeners,
for certainly the students
that are listening,
those of us that may mentor students
or just all of us in our careers,
to learn from what we're
hearing from Dr. Askar,
you might start down one pathway,
and sometimes, you wanna
hit pause, take a step back,
really might be the right step forward.
I think there's a lotta
momentum sometimes,
that students feel a
little bit of pressure
to not be able to hit pause and examine.
- Don't let me get started.
I mean, I was laughing
stock for my friends,
who were training in orthopedic surgery,
cardiothoracic surgery, neurosurgery,
and they just kept looking at me,
why you are wasting your education,
when you gonna stop this nonsense
and train in a real specialty,
and things of that nature.
- And here I am,
also as a histocompatibility person,
that sees how you're
really shaping this society
and shaping how transplantation
occurs in our world today.
This kinda leads me to my next question,
which is, transplantation, I think, is,
on some levels, may be easy
for people to understand,
but on other levels, it's quite complex,
and it certainly is a big team effort.
And so I'm curious, since
we have a broad audience,
what are a few things that you think
healthcare professionals in general,
laboratory professionals,
clinicians/students,
should understand about
organ transplantation?
- I would say,
it is really the most
altruistic form of human nature
to give someone parts of you.
It's really, there isn't
anything like that,
so it involves a lot of ethics,
a lot of higher thinking,
a lot of system thinking
and societal thinking.
And also, there is this fact
that we have organ shortage worldwide,
so we are stewards of
a very scarce resource.
So every patient you give a transplant,
you are taking it away from somebody else,
so it's really how you make the balance
between serving the
patient you are looking at,
but keeping in mind the
wellbeing of the entire society.
Not many branches of medicine
have this intellectual part.
There is also, as you mentioned,
it is probably the most interdisciplinary,
and it is, you have so many specialties,
medicine and pharmacy
and even dentistry.
Patients need to get
clearance from dentistry
to make sure that they don't
develop problems with that.
It affects everyone,
so we talked about having a new life,
so probably obstetrics
colleagues have that,
but they have it for
a very limited subset,
for women and childbearing age.
But anyone can be recipient of transplant,
even one year old, 70 year
old, men, women, everyone,
so it's really fascinating field to be in.
- One of the things in
your answer that makes me,
that kind of resonates
with me is this concept of,
I think a lotta times in healthcare,
we're thinking about the,
you know, at Mayo Clinic,
"The needs of the patient
come first," is our motto.
We're always thinking about the patient
that is in front of us,
and I'm certain that early
in your surgical career,
there's a lot of focus on,
this is the patient in front of us.
This is the correct decision
to make for this patient.
But like you're saying,
when you're talking
about organ transplant,
it gets more complex.
I think for a lotta people maybe a little,
I mean, ethics might be something
that is intuitive as a challenge
that comes in with transplant,
but just to talk about thinking about it
in terms of a systems way of thinking,
that might be a little bit novel
for some of our listeners to think about.
Can you maybe elaborate about,
maybe for you as somebody,
who was practicing first
in orthopedic surgery
and then making this
transition to systems thinking,
what has that been like,
and how do you navigate that now?
- Yeah, I mean like in surgery,
the best solution for the patient
is naturally is gonna be
the best solution for the society.
You want your patients,
whatever intervention you're
gonna do them to help them,
reconstruction or whatever
to make them more functional,
is what is gonna help with the society.
Of course, there are challenges
in terms of cost and whatnot,
but in organ transplantation,
when we had a 70 year old man
who needs a second heart transplant,
see, the levels of
complexity, and by giving,
so for this patient, this is
the only life saving option,
but you are taking it away
from a 20 year old young man,
who never received that transplant before,
and so what's best for this patient
might not be what's best for
the entire society as a whole.
- Wow, what a fascinating
area of practice.
Maybe now I was wondering,
if we could kind of like
pull back the curtain
a little bit for our listeners,
and can you talk a little bit about
how does the laboratory
and histocompatibility,
how does it actually support
organ transplantation?
You mentioned a lot of the complexity
and a lot of the interdisciplinary.
How about in the laboratory?
What kind of work happens behind the scene
that enables this transplant
to be as successful as possible?
- Yeah, so the lab function.
Actually, it's interesting.
I'm actually overseas giving,
just to give a talk this morning
about how lab can support
solid organ transplant,
so this is the subject of the talk I give.
And we really need to keep in mind that,
this is something I always
tell medical students
who are thinking about careers,
tell them that transplantation is
the most sophisticated
way of doing medicine.
So, imagine how infectious disease doctors
struggle with multi-drug
resistant microorganism.
Imagine the level of
complexity in giving this
for a patient under immunosuppression.
So it is just everything
we do in transplantation
is way more complex
than what you do for
non-transplant patient.
And keeping that in mind,
we do a series of tests for determining
the type of tissues of the patient,
and the categorically,
we try to do tests to help us determine
how to avoid unacceptable mismatches,
like differences in tissues
between the donor and the recipient,
that is gonna elicit either immediate
or very short term complication,
such as hyperacute rejection.
If you have very high level
of donor specific antibodies,
those can lead to hyperacute rejection,
and there is also the
next layer once we do that
is to maximize compatibility,
to get the closer tissues,
and that will help us
in mid range and long term outcomes.
The closer the nature of the tissues
of the donor and recipient,
the better survival advantage you get.
So that's at the like operational level,
but there are also so many
other things that the lab does
in terms of communication and education
for interdisciplinary teams
and helping them
interpret our test results
and how to apply it in
different clinical contexts.
- So, that's kind of,
maybe you could for our listeners,
you're talking a lot about
how we're determining compatibility,
and that's really in
this, I think about that,
maybe our listeners
are thinking about that
in kinda the acute phase
of when a transplant
decision is made to proceed.
Is the laboratory involved
with the care of the transplant patient
beyond the acute transplant?
What does that look like?
- So,
historically, maybe a decade ago or so,
it was the idea that we gonna do
as much compatibility assessment
at time of transplant,
pre-transplant, in donor selection,
and at time of transplant,
and we did our best,
and then we gonna hope
that we're gonna manage the
patient with immunosuppression.
But actually, that turned out
to be easier said than done,
because these patients develop
new immune responses to the grafts
and really ongoing
monitoring becomes necessity
rather than commodity.
And actually,
there are very exciting
new tests developing
for determining tissue
injury of the graft,
such as cell-free DNA
and non-invasive liquid biopsy techniques,
so there are a lot of developments
that we need,
like ongoing partnership
between the lab and the
clinical transplants team,
to ensure that these transplanted organs
last as long as they possibly can.
- That really dovetails into
kinda my final question,
which I'm sure all the listeners
are really interested to hear,
what do you predict is on the horizon
for histocompatibility?
- I think for the longest
time and until now,
we struggle with the organ shortage.
There aren't enough
organs to give to everyone
who have end stage organ failure,
and there are fundamental solutions
that are starting to emerge,
that have been contemplated
for the longest time,
but now we are seeing them
really emerging more into reality,
such as xenotransplantation,
which is using organs
from animals because,
at least hypothetically,
you can mass produce them
to satisfy all the needs.
There is also the
technology of gene editing,
that facilitates transforming
these organs from animals
into a more acceptable
immunologically format, if you may,
for the immune system of the recipient.
There is also the area of
bioengineering of organs
from stem cells through 3D printing,
so there are so many exciting
things happening at this time,
and hopefully, it will all help to address
the problem of organ shortage.
- Wow, that's fascinating.
It really kinda highlights
for our listeners
just how dynamic this field is, right.
You've mentioned several different ways
and fronts that we're working on
to improve organ transplantation.
Is there something, advice that you share,
like when you have people say like,
"How can I support organ transplantation?"
Maybe they don't,
people don't work in a
histocompatibility laboratory,
but how could the general public,
how could somebody support
organ transplantation?
- I think understanding that
we cannot have more organs than we need,
and we really need to promote
the concept of organ donation,
however, both in deceased donor setting
and in live donor settings.
And actually, a couple of
our colleagues, as you know,
actually donated their kidneys
just to set example for people to follow.
So if you are unable to donate
an organ during your life,
I think the minimum you do is
to become a registered donor,
when God forbid, the time comes.
And I think helping in,
as much as possible,
to educate the public and promote that
how every deceased donor
can save up to 8 lives
and can impact up to 75 others,
so there is just this exponential
benefit to the society
that can come from everyone contributing
and increasing the
awareness of the problem
for organ transplantation.
- And just to clarify for the listeners,
when you say 8 lives,
that's 8 vital organs
that are transplanted,
and up to 75 people can be touched,
that's tissues that can be donated.
- Yes.
- Phenomenal, so I think,
that really kinda tops off
why we're having this conversation,
why this episode is our holiday episode.
So thank you so much, Dr.
Askar, for rounding with us
and to talk about the ultimate gift
of organ transplantation.
You certainly, this podcast
episode, I think, serves
to help educate people
about transplantation,
and hopefully, this encourages listeners
to share this episode
and also to promote registering as donors.
- Thank you very much,
Justin, it's a pleasure.
- And to all of our listeners,
thank you for joining us today.
We invite you to share
your thoughts and suggestions via email.
Email them to mcleducation@mayo.edu.
And if you've enjoyed this
podcast, please subscribe.
Until our next rounds together,
we encourage you to continue to connect
lab medicine and a clinical practice
through insightful conversations.
(bright pulsing electronic music)